TherOx Downstream System
Zoll Circulation, Inc. · Decision date Apr 10, 2026
What did the FDA approve?
FDA records P170027/S018 as a supplement to PMA P170027, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Apr 10, 2026.
FDA approval order statement
approval of the revised protocol for the post-approval study (PAS)
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Cardiovascular
- Decision date
- Apr 10, 2026
- FDA change category
- Postapproval Study Protocol
Regulatory record facts
- Identifier
- P170027/S018
- Regulatory pathway
- PMA supplement
- Applicant
- Zoll Circulation, Inc.
- Product code
- MWG
- Decision code
- APPR
- Decision date
- Apr 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, oxygen, aqueous.
- Applicant
- Zoll Circulation, Inc.
- Product code
- MWG
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P170027/S018 received
Application receipt date recorded by FDA.
P170027/S020 · Related supplement
TherOx Downstream System
P170027/S018 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P170027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TherOx Downstream SystemP170027/S020 | Zoll Circulation, Inc. | PMA supplement | Oct 29, 2025 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Zoll Circulation, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2000 Ringwood Ave., San Jose, CA, 95131
Sources and methodology
- Original FDA record: P170027/S018
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records